The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, R.
Right arrow Articles by Reske-Kunz, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, R.
Right arrow Articles by Reske-Kunz, A. B.
The Journal of Immunology, 1998, 160: 3776-3782.
Copyright © 1998 by The American Association of Immunologists

The Actin-Bundling Protein Fascin Is Involved in the Formation of Dendritic Processes in Maturing Epidermal Langerhans Cells1

Ralf Ross, Xiao-Lan Ross, Jens Schwing, Tina Längin and Angelika B. Reske-Kunz2

Clinical Research Unit, Department of Dermatology, Johannes Gutenberg University, Mainz, Germany


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Dendritic cells (DC) are characterized by their unique potential to prime naive T cells. Epidermal Langerhans cells (LC), the DC resident in the epidermis, gain this immunostimulatory capacity following Ag contact in vivo or during in vitro culture of epidermal cell suspensions. To analyze differential gene expression in maturing LC, we constructed a highly representative cDNA library of cultivated LC (cLC) in {lambda} ZAP II containing 18 x 106 independent clones. This library was screened with freshly isolated Langerhans cell (fLC)- and cLC-derived probes for cLC-specific cDNAs. The cDNAs identified were sequenced and analyzed by database searches. Two cDNA fragments were identified as fragments of fascin, indicating that fascin is differentially expressed in LC. By competitive RT-PCR, we confirmed that fascin is highly expressed in cLC cultivated for 1, 2, and 3 days, while no signals were obtained with fLC. Western blot and immunofluorescence analysis revealed cLC-specific expression of fascin on the protein level as well. Fascin is known to be involved in the organization of the actin cytoskeleton in cytoplasmatic extensions of nerve growth cones. Its differential expression in maturing LC coincides with the formation of numerous dendritic projections in LC. Their formation was inhibited by incubation of LC with fascin antisense oligonucleotides during cultivation. Therefore, we conclude that fascin is necessary for the formation of the dendritic processes of maturing Langerhans cells and may thus influence T cell-LC interaction.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Bone marrow-derived dendritic cells (DC)3 are pivotal for the induction of an acquired immune response, since among APC they are uniquely able to prime naive T cells. Epidermal Langerhans cells (LC) are characterized as a uniformly immature subpopulation of DC not yet capable of primary T cell activation (1). Following contact with Ag, LC capture the Ag and migrate via lymph vessels to the draining lymph nodes, thereby maturing into potent APC (2, 3). Now referred to as interdigitating DC, they present the processed Ag peptides bound to MHC class II molecules to naive T cells resulting in T cell activation. It is well established that LC maturation can be simulated by cultivating freshly isolated LC (fLC) for 3 days (cLC) in the presence of keratinocytes (4, 5).

The structural and functional changes that LC undergo during this process are numerous, and some of them pose special demands on the cytoskeleton: before activation, LC reside within the epidermis in contact with surrounding keratinocytes; once activated, LC leave their position and migrate actively to the draining lymph nodes. During movement they retract the few, but very long dendritic processes. Finally, within the lymph nodes they elaborate multiple thin projections. A network of actin filaments associated with actin-binding proteins is important for each of these processes, namely for movement and cell shape as well as for cell attachment (6). The attachment of LC to surrounding cells within the epidermis is mediated by homodimerization of E-cadherin molecules (7). E-cadherin is anchored within the cell to the actin cytoskeleton via actin-binding proteins (8). Activation and emigration of LC is associated with down-regulation of E-cadherin surface expression (9).

The three-dimensional network of actin filaments is structured by interaction of actin filaments with capping proteins and by cross-linking of the filaments via actin-binding proteins. A growing number of actin-binding proteins such as actinin, gelsolin, and villin has been identified, and differential expression of subsets of actin-binding proteins is necessary for specialized functions and structures (10, 11).

Ample evidence exists that the 55-kDa actin-bundling protein fascin organizes actin filaments into bundles (12, 13). It is, furthermore, likely to be involved in formation of dendritic projections, as it was detected in cells with dendritic processes such as neuronal growth cone filopodia and human blood-derived DC (14, 15). Here, we report that fascin is differentially expressed during maturation of murine LC. The formation of pronounced and numerous dendritic projections coincided with strong fascin expression and was impaired by fascin antisense oligonucleotides.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals

BALB/c Ann mice were bred in our animal facilities from breeding pairs originally obtained from the Zentralinstitut für Versuchstierkunde (Hannover, Germany). The mice were used at 2 to 5 mo of age.

Monoclonal Abs

Clone 2G9 (anti-I-Ad,b, I-Ed, rat IgG2a) (16) was a kind gift from Dr. M. Mohamadzadeh, Department of Dermatology, University of Mainz, Germany. 55K-2 mAb (anti-human fascin, mouse ascites) (17) was a kind donation by Dr. F. Matsumura, Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ. Isotype control mAb were obtained from PharMingen, Hamburg, Germany.

Cell lines

The Th line BK-OVA-1R (18) recognizes OVA in the context of A{alpha}bk MHC class II molecules. The murine B cell lymphoma A20/2J (19), the macrophage cell line P388D1 (20), the fibroblast line WEHI-164 (21), and the melanocyte line B78 (22) were cultured as described before. Cells were harvested and used directly for mRNA preparation or Western blots, or alternatively, cell pellets were shock frozen in liquid nitrogen and stored at -70°C for later analysis.

Preparation of fLC and cLC

Epidermal cell suspensions were prepared from pelts as described previously (23). They were used for LC enrichment either directly or following in vitro cultivation for 1 to 3 days in Iscove’s modified Dulbecco’s medium (IMDM, Life Technologies, Eggenstein, Germany) supplemented with 2 mM L-glutamine, 5 x 10-5 M 2-ME, 100 IU penicillin, 100 µg/ml streptomycin, 12.5 µg/ml amphotericin B, 500 µg/ml gentamicin, and 10% FCS in 175 cm2 tissue culture flasks (Techno Plastic-Products, Trasadingen, Switzerland) (24).

LC were enriched from epidermal cells by immunomagnetic separation with Dynabeads M-450 (Dynal, Hamburg, Germany) loaded with anti-MHC class II mAb 2G9 as described (24). MHC class II-positive, bead-coupled LC and cells without attached beads were counted using a Neubauer chamber. LC purity of ~92 to 95% was obtained as determined by the ratio of bead-rosetted to nonrosetted cells. LC viability, determined by trypan blue exclusion, was >95%.

Mixed epidermal cell lymphocyte reaction

The mixed epidermal cell lymphocyte reaction was conducted as described (24). Briefly, nylon wool-enriched (25) splenic C57BL/6 T cells were stimulated with titrated numbers of allogeneic fLC or cLC of BALB/c origin. T cell proliferation was measured by incorporation of 28 kBq [3H]thymidine into cellular DNA during the last 12 h of a 96-h incubation period.

cDNA library construction

A cDNA library derived from cLC was constructed in {lambda} ZAP II (26). mRNA was isolated from cLC (purity, 95% rosetted cells) using the QuickPrep mRNA Purification Kit (Pharmacia, Freiburg, Germany). Double-stranded cDNA was obtained from 5 µg mRNA using the Time Saver cDNA synthesis kit (Pharmacia) and ligated with EcoRI/NotI adaptors (Pharmacia) according to the recommendations of the manufacturer. The adaptor-flanked cDNA fragments were ligated with dephosphorylated, EcoRI-digested {lambda} ZAP II vector arms (Stratagene, Heidelberg, Germany) and were in vitro packaged using the in vitro packaging kit Gigapack II Gold (Stratagene).

Preparation of screening probes from fLC and cLC

The cDNA probes were prepared as we described recently (27). Briefly, double-stranded cDNA was obtained from approximately 100 ng mRNA derived from 106 fLC or cLC using the Time Saver cDNA synthesis kit (Pharmacia), ligated with Uni-Amp adaptors (Clontech Laboratories, Palo Alto, CA) and amplified by PCR in 25 cycles with 1 min denaturation at 94°C, 1 min annealing at 60°C, and 2 min extension at 72°C. The radioactive labeling of the double-stranded reamplified cDNAs was performed by random-primed oligo labeling using the Multiprime DNA labeling system (Amersham Buchler, Braunschweig, Germany).

Differential plaque filter screening

Bacteria and recombinant phages were plated on 24.5 x 24.5 cm culture dishes (Nunc, Roskilde, Denmark) in concentrations allowing the distinguishing of single plaques following cultivation overnight. The phages were transferred to nitrocellulose filters, and replicate filters from each plate were treated and hybridized according to Benton and Davis (28). One replicate filter was hybridized with a fLC-derived probe prepared as outlined above, while the corresponding filter was hybridized with a cLC-derived probe. Following autoradiography, the hybridization patterns were compared, and phages yielding cLC-specific signals were picked and replated. Replicate filters were rescreened with fLC- and cLC-derived probes.

Southern hybridization and sequencing

The internal pBluescript SK(-) plasmid containing the cLC-specific cDNA was recovered from pure, cLC-specific, recombinant {lambda} ZAP II phages by in vivo excision (26). The plasmid DNA, purified using the Plasmid Kit Midi (Qiagen, Hilden, Germany), was restricted, subjected to Southern hybridization (29), and sequenced using the T7 Sequencing Kit (Pharmacia) with vector-specific primers (T3A: AAT AAC CCT CAC TAA AGG G; and T7A: AAT ACG ACT CAC TAT AGG G) according to the recommendations of the manufacturer.

Competitive RT-PCR

mRNA was isolated using the Quick-Prep Micro mRNA Purification Kit (Pharmacia). The RNA concentration and quality were assessed by RT-PCR with primers specific for hypoxanthine-guanine phosphoribosyltransferase (HPRT-1: GGT TGG ATA CAG GCC AGA CTT TGT TG and HPRT-2: GAA GGG TAG GCT GGC CTA TAG GCT). The primers FAS-1 (CCC GCC TCA CTC TGG GAG TA) and FAS-2 (CTC CTA GGC CAC TTC CTG GG) were chosen to amplify a 329 bp fragment of fascin cDNA. For competitor construction, the hybrid primers FASST-1 (CCC GCC TCA CTC TGG GAG TAC CGC TCT AGG CAC CA) and FASST-2 (CTC CTA GGC CAC TTC CTG GGG TAC GAC CAG AGG CA) were used. All primers were generated by MWG-Biotech (Ebersberg, Germany).

RT-PCR was performed as described previously (30) using a model 480 DNA Thermal Cycler (Perkin-Elmer, Ueberlingen, Germany). The competitor fragment (365 bp) was constructed as we described earlier (30). It is flanked by the primer-binding sites for FAS-1 and FAS-2, but has no further sequence homology to fascin. For quantitative analysis of the PCR reactions, equal amounts of the competitor fragments were added to each PCR reaction (30).

Western blotting

Tissues were shock frozen, pulverized under liquid nitrogen in a mortar, and resuspended in SDS sample buffer. Following ultrasonic treatment, protein concentration was determined by Bradford assay (Bio-Rad, München, Germany). Aliquots equivalent to 105 cells or 5 µg protein, respectively, per lane were separated on 15% SDS-PAGE gels and transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA). Bound primary Ab (anti-human fascin mAb 55K-2) was visualized by horseradish peroxidase-labeled anti-mouse Ig Ab using the BM Chemiluminescence Western Blotting Kit (Boehringer Mannheim, Mannheim, Germany) following the recommendations of the manufacturer.

Immunofluorescence

For fluorescence staining, epidermal cells were grown on coverslides or were transferred onto glass slides by centrifugation (cytospin) for 1 min. Epidermal cells for cytospins were either used directly or following three day cultivation and Ficoll density centrifugation (Histopaque, density 1.077; Sigma, Deisenhofen, Germany). All preparations were fixed for 10 min in 90% aceton at -20°C, washed three times in PBS, and incubated overnight at 4°C or 3 h at 37°C with the primary mAb (55K-2 and 2G9). Following three washes in PBS, cells were incubated for 1 h at 37°C with dichlorotriazinyl aminofluorescein (DTAF)-conjugated goat anti-mouse IgG (0.75 µg) and with phycoerythrin-labeled goat anti-rat IgG (0.5 µg) secondary Abs (both from Dianova, Hamburg, Germany).

Cultivation of LC with antisense oligonucleotides

Epidermal cell suspensions were prepared from pelts (23) and cultivated as described on 8-well or 16-well chamber slides (Nunc). Cells were cultivated either without addition of oligonucleotides or with fluorescein-labeled (0.5 µM) or unlabeled (2 µM) phosphorothioate oligonucleotides. An antisense oligonucleotide (FAS), the reverse complement to the murine and human fascin mRNA, was used as well as a matched control oligonucleotide of the same length (15 bp) and base content, which had similar hybridization characteristics and showed no cross-homology to any known gene. The HPLC-purified oligonucleotides were purchased from Biognostik, Göttingen, Germany. Oligonucleotides were added to epidermal cell suspensions at the beginning of the 3-day cultivation period.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
fLC and cLC prepared as described met the criteria reported in the literature. Thus, cLC, but not fLC, derived from BALB/c mice (H-2d) were efficient stimulator cells for nylon wool-enriched T cells from C57BL/6 mice (H-2b) (data not shown). On the other hand, fLC were capable of processing OVA and presenting OVA-peptides to the T cell hybridoma 3DO-54.8, that recognizes OVA in the context of I-Ad (data not shown). Furthermore, we detected enhanced surface expression of the costimulatory molecules B7.1, B7.2, ICAM-1, and LFA-3 on cLC, as compared with fLC, and up-regulated mRNA expression of ICAM-1 in cLC, while mRNA expression of MHC class II was down-regulated (data not shown).

Construction, validation, and differential screening of a cLC-derived cDNA library in {lambda} ZAP II

cLC (5 x 107, purity > 95% rosetted cells) were subjected to mRNA isolation. The integrity of the mRNA was analyzed by Northern blotting and hybridization with ß-actin cDNA probes. A clear, distinct signal was obtained (data not shown). Five micrograms of mRNA was used for generation of double-stranded cDNA, subsequent ligation into {lambda} ZAP II, and in vitro packaging. Determination of the phage titer of the cDNA library indicated that the library contained 1.8 x 107 independent clones. Based on blue/white-screening, we estimated that 90% of the clones were recombinant. Five randomly picked clones contained cDNA fragments of 300 to 1900 bp. By plaque filter hybridization of 3000 clones with ß-actin cDNA probes, we obtained eight ß-actin cDNA clones (not shown).

Approximately 20,000 clones of the cLC-derived cDNA library were plated onto 24.5 x 24.5-cm culture dishes; replicate filters were taken and hybridized with fLC- or cLC-derived probes, respectively, that had been validated before, as described earlier (27). The hybridization patterns of the replicate filters with fLC- and cLC-derived probes were compared. Fifty clones yielding strong signals with cLC-derived probes and weak or no signals with fLC-derived probes were selected, replated, and rescreened (Fig. 1Go). Thirty-eight clones yielded cLC-derived signals.



View larger version (79K):
[in this window]
[in a new window]
 
FIGURE 1. Isolation of cLC-specific cDNAs by differential screening of a cLC-derived cDNA library. A cLC-derived cDNA library was plated on culture dishes. Replicate filters were taken and hybridized with fLC- and cLC-derived probes. cLC-specific clones were picked and rescreened. Upper panel, Corresponding areas of replicate filters of a cLC-derived cDNA library hybridized with fLC-derived (d0) and cLC-derived (d3) probes. Numbers indicate corresponding clones. A clone yielding strong signals with cLC-derived probes, but not with fLC-derived probes is marked (arrows). Lower panel, Phages from an area containing a cLC-specific clone were recovered and replated, and replicate filters were hybridized with fLC-derived (d0) or cLC-derived (d3) probes. Single plaques yielding cLC-specific signals were picked. Sequencing followed by database searches revealed that the clone contained a fascin cDNA.

 
Analysis of the isolated cLC-specific cDNA clones

The pBluescript phagemids containing the cLC-specific cDNAs were recovered by in vivo excision from all 38 isolated {lambda} clones. Plasmid DNA was isolated and digested with EcoRI. The restriction pattern revealed similar patterns for a number of clones. Therefore, one of them was radioactively labeled and subjected to Southern hybridization with blots of all 38 clones. Twenty-two clones yielded strong signals indicating that homologous or identical cDNAs were cloned. Two of the hybridizing clones and the 16 remaining nonhybridizing cDNAs were sequenced from both ends with the vector-specific primers T3A and T7A.

Comparison of the sequences obtained with the Geall databases (Deutsches Krebs-Forschungszentrum, Heidelberg, Germany) revealed that the cross-hybridizing clones contained identical cDNAs of a so far unknown gene. Two of the remaining cDNAs were identical with the murine fascin cDNA (accession No. L33726). The clone pcLC12 contained a nearly complete cDNA of 2587 bp, while clone pcLC5 contained 1221 bp of the 3' end (Fig. 2GoA). Fascin was selected for further investigation, as a mAb was available (17), its ability to organize actin into bundles was known (12, 13), and its functional role in organizing the actin cytoskeleton promised to be of importance.



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 2. Differential expression of fascin mRNA by competitive RT-PCR. A, Schematic view of the fascin mRNA (2634 bp). The coding region is boxed, and the locations of the primer sequences and the fragment amplified by PCR are marked. The isolated cDNA clones pcLC 5 and pcLC 12 are shown below. B, Competitive RT-PCR with fascin-specific primers. Equal amounts of competitor fragments (upper bands) were added to serial dilutions of RT reactions of fLC (d0) and cLC cultivated for 1 (d1), 2 (d2), or 3 (d3) days (lower bands). The RT reactions were diluted twofold per lane from left to right. st, Indicates amplification of competitor fragments without RT reaction. Marker: {Phi}X174 x HaeIII. C, The concentration and quality of the mRNA used in B, derived from fLC (d0) and cLC cultivated for 1 (d1), 2 (d2), or 3 (d3) days, was assessed by RT-PCR. Aliquots of the same RT reaction as described in B were amplified with specific primers for the housekeeping gene, HPRT. c, Indicates negative control without mRNA; m, molecular weight marker {Phi}X174 x HaeIII.

 
Analysis of fascin expression in LC by RT-PCR

To analyze at what time point during maturation of LC fascin expression is induced, we performed competitive RT-PCR using mRNA isolated from equal numbers of fLC and from cLC cultivated for 1, 2, and 3 days. Equal amounts of mRNA were subjected to reverse transcription, and aliquots were used for PCR with specific primers for the housekeeping gene, HPRT. Signals of equal intensity were obtained indicating comparable amounts of mRNA (Fig. 2GoC). Aliquots of the same RT reaction were used for PCR with fascin-specific primers. Serial dilutions of the RT reaction were mixed with a constant amount of competitor molecules. The competitor molecules were generated as we described recently (27). They are flanked by the primer-binding sites for the fascin primers but have no further homology to fascin to minimize cross-hybridizations. Following gel electrophoresis, competitor-derived (upper bands; 365 bp) and cDNA-derived (lower bands; 329 bp) fragments were distinguishable by size. As shown in Figure 2GoB, no fascin signals were obtained with fLC, while strong signals were obtained with cLC cultivated for 1, 2, and 3 days. The signal intensities on days 1 through 3 were similar.

Detection of fascin protein by immunofluorescence analysis in cLC, but not in fLC

Freshly isolated or 3-day-cultured epidermal cells were transferred onto glass slides by cytospin. Double fluorescence labeling for MHC class II (red) and fascin (green) revealed that fLC, identified by bright MHC class II staining, were negative for fascin staining, while cLC were clearly positive (Fig. 3Go). MHC class II-negative cells, either freshly isolated or cultivated, were negative for fascin staining. With isotype-matched control Ab, no staining was observed.



View larger version (80K):
[in this window]
[in a new window]
 
FIGURE 3. Detection of fascin in cLC, but not in fLC, by immunofluorescence. Immunofluorescence staining of fLC and cLC transferred onto glass slides by cytospin was performed. a, d, and g, Phase contrast control. The cells were analyzed with epifluorescence filter sets detecting phycoerythrin labeling (red, anti-MHC class II staining; b, e, and h) and DTAF labeling (green, anti-fascin staining, c, f, and i). a–c, fLC; d–f, cLC; g–i, cLC with isotype-matched control mAbs. Scale bar represents 30 µm.

 
To analyze the distribution of fascin within the cell, we grew epidermal cells on cover slides in 6-well culture dishes for 3 days and double stained with anti-MHC class II and anti-fascin mAb. cLC showed elaborate dendritic morphology (Fig. 4Goa). The entire cells, including all dendritic processes, stained clearly positive for fascin (Fig. 4Gob).



View larger version (82K):
[in this window]
[in a new window]
 
FIGURE 4. Expression and distribution of fascin on cLC. Immunofluorescence staining of cLC grown on cover slides was performed. The cells were analyzed with epifluorescence filter sets detecting phycoerythrin-labeled anti-MHC class II staining (a) and DTAF-labeled anti-fascin staining (b). Scale bar represents 20 µm.

 
Analysis of fascin expression by Western blotting

Extracts of equal numbers of fLC and cLC separated by paramagnetic beads coupled with anti-MHC class II mAb, as well as equal amounts of protein derived from brain, liver, spleen, and kidney, were subjected to Western blotting. Fascin was detected by mAb 55K-2 only in extracts of cLC, but not of fLC (Fig. 5Go). The estimated molecular mass (approximately 55 kDa) of the corresponding protein is identical with that of fascin. In addition, a prominent fascin signal was obtained with brain extract (Fig. 5Go), which is compatible with the notion that fascin is highly expressed in neurons and glial cells (31). A strong signal was obtained with splenic cells as well. Weak signals were obtained with kidney and liver cells. Among a panel of cell lines including B cells, T cells, macrophages, fibroblasts, and melanocytes, only the fibroblast cell line yielded a fascin signal (Fig. 5Go). No signals were obtained with isotype control Abs (not shown).



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 5. Differential expression of fascin in murine cell types and tissues. Extracts of equal numbers of fLC (d0), cLC (d3), the murine Th line BK-OVA-1R (BK-OVA), the B cell lymphoma A20/2J, the fibroblast line WEHI-164 (WEHI), the macrophage line P388D1, and the melanocyte line B78 as well as equal amounts of total brain, liver, spleen, and kidney protein from BALB/c mice were subjected to SDS-PAGE and Western blotting. Equal protein loading was ensured by using the Bradford assay and Coomassie staining of aliquots loaded on neighboring lanes of the same gel. Fascin expression was detected by chemiluminescence using mAb 55K-2. With isotype-matched control mAb, no signals were obtained (not shown).

 
Dendritic morphology of cLC is inhibited by fascin antisense oligonucleotides

Epidermal cells were cultivated in 8- or 16-well chamber slides, with or without addition of phosphorothioat oligonucleotides, for 3 days. The class II-positive cLC were then immunostained with mAb 2G9. Incubation with 2 µM FAS oligonucleotides (reverse complement to murine and human fascin mRNA) clearly inhibited the formation of dendritic projections (Fig. 6Goc) compared with untreated cells (Fig. 6Goa). In parallel experiments, 2 µM control oligonucleotides were added to rule out cytotoxic or nonspecific effects of the antisense oligonucleotides (Fig. 6Gob). Cellular uptake was monitored by addition of 0.5 µM fluorescein-labeled oligonucleotides (Fig. 6God).



View larger version (70K):
[in this window]
[in a new window]
 
FIGURE 6. Dendritic morphology of cLC is impaired by fascin antisense oligonucleotides. Freshly isolated epidermal cells from BALB/c mice were cultivated without addition of oligonucleotides (a), with 2 µM control oligonucleotides (b), or with 2 µM fascin antisense oligonucleotides (c) for 3 days. MHC class II-positive cLC were phycoerythrin labeled using mAb 2G9. Cellular uptake of 0.5 µM fluorescein-labeled oligonucleotides is shown in d. Scale bar represents 20 µm.

 
Class II-positive cLC within wells containing untreated cells or cells treated with control oligonucleotides (control) or FAS antisense oligonucleotides (FAS) were microscopically examined by the experimenter and grouped into either of two categories according to the following criteria: category 1 cLC were large cells of irregular shape with or without dendritic projections (part of the cLC lost their dendritic protrusions during the immunostaining procedure); category 2 cLC were small, round cells without dendritic projections. As depicted in Figure 7Go, category 1 cLC outnumbered category 2 cLC by a factor of 4, when the epidermal cells had been cultured without addition of oligonucleotides. In cultures to which control oligonucleotides had been added, a factor of 3.2 resulted. In contrast, when FAS antisense oligonucleotides were present during cultivation of epidermal cells, category 1 cLC were outnumbered by category 2 cLC (factor of 0.2).



View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 7. Effect of fascin antisense oligonucleotides on the morphology of cLC. Freshly isolated epidermal cells from BALB/c mice were cultivated without addition of oligonucleotides (-), with 2 µM control oligonucleotides (control), or with 2 µM fascin antisense oligonucleotides (FAS) for 3 days. MHC class II-positive cLC were phycoerythrin labeled using mAb 2G9. Class II-positive cells were microscopically grouped into either category 1 cLC (large cells of irregular shape with or without dendritic projections, blank columns); or category 2 cLC (small, round cells without dendritic projections, shaded columns). Data are expressed as percentage of class II-positive cells ± SD for five independent experiments. A total of 1826 class II-bearing cells was evaluated in the untreated cultures, 1498 cells in the control oligonucleotide cultures, and 1596 cells in the FAS oligonucleotide cultures.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Using the strategy of differential screening of a cLC-derived cDNA library with fLC- and cLC-derived probes, we identified differential gene expression of the fascin gene in maturing epidermal LC.

The results obtained by differential screening were confirmed by investigations on the mRNA and protein level, indicating that the screening procedure and the probes generated for screening were reliable. While fascin was not detectable on the mRNA level in fLC, we detected significant expression of mRNA by quantitative RT-PCR already on day 1 and comparable transcript levels on day 2 and 3 of culture. For detection of fascin expression on the protein level, mAb 55K-2 was used (17). Although generated against human fascin, this mAb cross-reacts with the homologous proteins of mouse and Xenopus, as the gene is highly conserved (32). Differential expression of fascin mRNA was paralleled by differential expression of fascin protein. The data indicate that fascin expression is regulated on the mRNA level and that fascin may be required early after activation as well as at later time points. Expression of fascin in mouse cLC is compatible with results published recently by Mosialos et al. (15) and Pinkus et al. (33) showing that fascin is highly expressed in human DC. Furthermore, we observed high levels of fascin in spleen, known to harbor elevated numbers of mature DC. Weak fascin signals with cells derived from kidney and liver may be due to DC resident in these organs. Whether DC contribute to fascin expression in these organs has to be shown in further studies.

Many blood-derived or skin-derived cell types do not express fascin. Thus, fascin was not expressed in fLC and in freshly isolated and in cultured MHC class II-negative epidermal cells, as indicated by immunofluorescence, and was not detectable by Western blotting in several murine cell lines including B cells, T cells, macrophages, and melanocytes.

Fascin expression is, however, not restricted to DC. It was reported to be expressed in fibroblasts, neurons, glial cells, and in EBV-transfected B cells, but not in untransfected T cells and B cells (17, 31). Accordingly, we obtained strong fascin signals with murine brain cells and with the murine fibroblast cell line WEHI-164. Nevertheless, lacking deal markers for DC, fascin may serve as a marker molecule for DC, taking into account its strong expression in cLC and its absence in many other blood- and skin-derived cell types. Furthermore, fascin may serve as a marker for maturing LC and possibly other DC.

The actin cytoskeleton is essential for a number of important cellular functions including motility (34, 35), exocytosis (36), phagocytosis (37), formation of stress fibers (34), activity of ion channels and transport proteins (38), cell surface receptor perturbation (39), cell polarity, and contact to extracellular matrix components (40). It is not yet clear whether fascin is involved in these processes. Fascin organizes actin into bundles in vitro, and Drosophila singed mutants deficient in the Drosophila fascin homologue show that fascin is required for proper bristle formation as well as formation of actin filaments in nurse cells during oogenesis (12). The limited expression of fascin and the differential expression in LC eliminate the possibility that it might be of crucial importance for most of the processes listed above, e.g., fLC show phagocygotic activity despite lack of detectable fascin expression. Fascin may be involved in formation and/or motility of the newly shaped dendritic processes. It might not be merely coincidence that the cells with the most elaborated projections, namely DC and neurons, express fascin. In neurons, fascin protein is not detectable in axons; it is restricted to the cytoplasm of the cell body and expressed particularly in the dendritic processes of the nerve growth cone (14). The latter strikingly resemble dendritic projections of cLC and other DC in shape and are mobile as well. In neurons, this movement might be necessary in the course of the pathfinding and growth of the axon to its destination. In DC, this active movement allows DC to attach to T cells and to interact with them closely. Fascin is expressed within the dendritic projections of cLC. As these cover the entire surface of the cell, there are no regions that might be devoid of fascin.

The fact that anti-fascin oligonucleotides impair the dendritic morphology of cLC strongly supports the view that fascin is pivotal for the formation of numerous dendritic projections of maturing LC. It is unlikely that the impaired dendritic morphology is due to unspecific effects of the antisense oligonucleotides, as the number of cells with dendritic morphology is only slightly reduced by the same concentration of control oligonucleotides. As the dendritic projections are likely to support and enhance the LC-T cell contact, fascin could be involved indirectly in the process of Ag presentation and T cell stimulation.


    Acknowledgments
 
We thank Dr. F. Matsumura for his generous gift of 55K-2 mAb.


    Footnotes
 
1 This work was supported by the Deutsche Forschungsgemeinschaft, Kn120/6-1 and Kn120/6-3. Back

2 Address correspondence and reprint requests to Dr. A. B. Reske-Kunz, Klinische Forschergruppe Allergie, Universitäts-Hautklinik/Verfügungs-gebäude, Obere Zahlbacher Strasse 63, D-55131 Mainz. Back

3 Abbreviations used in this paper: DC, dendritic cell(s); fLC, freshly isolated Langerhans cell(s); cLC, cultured Langerhans cell(s); DTAF, dichlorotriazinyl aminofluorescein; HPRT, hypoxanthine-guanine phosphoribosyltransferase. Back

Received for publication September 17, 1997. Accepted for publication December 19, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Inaba, K., G. Schuler, M. D. Witner, J. Valinsky, B. Atassi, R. M. Steinman. 1986. Immunologic properties of purified epidermal Langerhans cells. J. Exp. Med. 164:605.[Abstract/Free Full Text]
  2. Kripke, M. L., C. G. Munn, A. Jeevan, J. M. Tang, C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145:2833.[Abstract]
  3. Macatonia, S. E., S. C. Knight, A. J. Edwards, S. Griffiths, P. Fryer. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166:1654.[Abstract/Free Full Text]
  4. Schuler, G., R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526.[Abstract/Free Full Text]
  5. Heufler, C., F. Koch, G. Schuler. 1988. Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167:700.[Abstract/Free Full Text]
  6. Stossel, T. P.. 1993. On the crawling of animal cells. Science 260:1086.[Abstract/Free Full Text]
  7. Tang, A., M. Amagai, L. G. Granger, J. R. Stanley, M. C. Udey. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361:82.[Medline]
  8. Rimm, D. L., E. R. Koslov, P. Kebriaei, C. D. Cianci, J. S. Morrow. 1995. Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc. Natl. Acad. Sci. USA 92:8813.[Abstract/Free Full Text]
  9. Schwarzenberger, K., M. C. Udey. 1996. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106:553.[Medline]
  10. Bretscher, A.. 1991. Microfilament structure and function in the cortical cytoskeleton. Annu. Rev. Cell Biol. 7:337.
  11. Hartwig, J. H., D. J. Kwiatkowski. 1991. Actin-binding proteins. Curr. Opin. Cell Biol. 3:87.[Medline]
  12. Cant, K., B. A. Knowles, M. S. Mooseker, L. Cooley. 1994. Drosophila singed, a fascin homolog, is required for actin bundle formation during oogenesis and bristle extension. J. Cell Biol. 125:369.[Abstract/Free Full Text]
  13. Edwards, R. A., H. Herrera Sosa, J. Otto, J. Bryan. 1995. Cloning and expression of a murine fascin homolog from mouse brain. J. Biol. Chem. 270:10764.[Abstract/Free Full Text]
  14. Sasaki, Y., K. Hayashi, T. Shirao, R. Ishikawa, K. Kohama. 1996. Inhibition by drebrin of the actin-bundling activity of brain fascin, a protein localized in filopodia of growth cones. J. Neurochem. 66:980.[Medline]
  15. Mosialos, G., M. Birkenbach, S. Ayehunie, F. Matsumura, G. S. Pinkus, E. Kieff, E. Langhoff. 1996. Circulating human dendritic cells differentially express high levels of a 55-kD actin-bundling protein. Am. J. Pathol. 148:593.[Abstract]
  16. Becker, D., M. Mohamadzadeh, K. Reske, J. Knop. 1992. Increased level of intracellular MHC II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens. J. Invest. Dermatol. 99:545.[Medline]
  17. Yamashiro Matsumura, S., F. Matsumura. 1986. Intracellular localization of the 55-kD actin-bundling protein in cultured cells: spatial relationships with actin, alpha-actinin, tropomyosin, and fimbrin. J. Cell Biol. 103:631.[Abstract/Free Full Text]
  18. Reske-Kunz, A. B., D. von Steldern, E. Rüde, T. Diamantstein. 1986. Regulation of interleukin 2 receptor expression by interleukin 2. Scand. J. Immunol. 23:693.[Medline]
  19. Kim, K. J., C. Kanellopoulos-Langwin, R. M. Merwin, D. H. Sachs, R. Asofsky. 1979. Establishment and characterization of BALB/c-lymphoma lines with B cell properties. J. Immunol. 122:549.[Abstract/Free Full Text]
  20. Koren, H. S., B. S. Handwerger, J. R. Wunderlich. 1975. Identification of macrophage-like characteristics in a cultured murine tumor line. J. Immunol. 114:894.[Abstract/Free Full Text]
  21. Ziegler Heitbrock, H. W., G. Riethmuller. 1984. A rapid assay for cytotoxicity of unstimulated human monocytes. J. Natl. Cancer Inst. 72:23.
  22. Thayer, M. J., H. Weintraub. 1990. Activation and repression of myogenesis in somatic cell hybrids: evidence for trans-negative regulation of MyoD in primary fibroblasts. Cell 63:23.[Medline]
  23. Becker, D., A. Reske-Kunz, J. Knop, K. Reske. 1991. Biochemical properties of MHC class II molecules endogenously synthesized and expressed by mouse Langerhans cells. Eur. J. Immunol. 21:1213.[Medline]
  24. Weigmann, B., J. Schwing, H. Huber, R. Ross, H. Mossmann, J. Knop, A. B. Reske-Kunz. 1997. Diminished contact hypersensitivity response in IL-4 deficient mice at a late phase of the elicitation reaction. Scand. J. Immunol. 45:308.[Medline]
  25. Julius, M. H., E. Simpson, L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645.[Medline]
  26. Short, J. M., J. M. Fernandez, J. A. Sorge, W. D. Huse. 1988. Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties. Nucleic Acids Res. 16:7583.[Abstract/Free Full Text]
  27. Ross, R., K. Kumpf, A. B. Reske-Kunz. 1997. PCR-amplified cDNA probes for verification of differentially expressed genes. Biotechniques 22:894.[Medline]
  28. Benton, W. D., R. W. Davis. 1977. Screening lambda gt recombinant clones by hybridization to single plaques in situ. Science 196:180.[Abstract/Free Full Text]
  29. Maniatis, T., E. F. Fritsch, J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual 382. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  30. Ross, R., R. Kleinz, A. B. Reske-Kunz. 1995. A method for rapid generation of competitive standard molecules for RT-PCR avoiding the problem of competitor/probe cross-reactions. PCR Methods Appl. 4:371.[Medline]
  31. Mosialos, G., S. Yamashiro, R. W. Baughman, P. Matsudaira, L. Vara, F. Matsumura, E. Kieff, M. Birkenbach. 1994. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. J. Virol. 68:7320.[Abstract/Free Full Text]
  32. Duh, F. M., F. Latif, Y. Weng, L. Geil, W. Modi, T. Stackhouse, F. Matsumura, D. R. Duan, W. M. Linehan, M. I. Lerman, J. R. Gnarra. 1994. cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein. DNA Cell Biol. 13:821.[Medline]
  33. Pinkus, G. S., J. L. Pinkus, E. Langhoff, F. Matsumura, S. Yamashiro, G. Mosialos, J. W. Said. 1997. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin’s disease. Evidence for a dendritic or B cell derivation?. Am. J. Pathol. 150:543.[Abstract]
  34. Heath, J. P., B. F. Holifield. 1993. On the mechanisms of cortical actin flow and its role in cytoskeletal organisation of fibroblasts. Symp. Soc. Exp. Biol. 47:35.[Medline]
  35. Verschueren, H., I. van der Taelen, J. Dewit, J. De Braekeleer, P. De Baetselier, K. Aktories, I. Just. 1995. Effects of Clostridium botulinum C2 toxin and cytochalasin D on in vitro invasiveness, motility and F-actin content of a murine T-lymphoma cell line. Eur. J. Cell Biol. 66:335.[Medline]
  36. Seidel, A., M. Hasmann, R. Loser, A. Bunge, B. Schaefer, I. Herzig, K. Steidtmann, M. Dietel. 1995. Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells. Virchows Arch. 426:249.[Medline]
  37. Kodama, H., T. Baba, I. Ohishi. 1994. Inhibition of phagocytosis by rainbow trout (Oncorhynchus mykiss) macrophages by botulinum C2 toxin and its trypsinized component II. Dev. Comp. Immunol. 18:389.[Medline]
  38. Mills, J. W., E. M. Schwiebert, B. A. Stanton. 1994. The cytoskeleton and membrane transport. Curr. Opin. Nephrol. Hypertens. 3:529.[Medline]
  39. Rao, K. M., J. Varani. 1982. Actin polymerization induced by chemotactic peptide and concanavalin A in rat neutrophils. J. Immunol. 129:1605.[Abstract]
  40. Bacallao, R.. 1995. The role of the cytoskeleton in renal development. Semin. Nephrol. 15:285.[Medline]



This article has been cited by other articles:


Home page
BloodHome page
R. Geyeregger, M. Zeyda, W. Bauer, E. Kriehuber, M. D. Saemann, G. J. Zlabinger, D. Maurer, and T. M. Stulnig
Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin
Blood, May 15, 2007; 109(10): 4288 - 4295.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Bros, F. Jahrling, A. Renzing, N. Wiechmann, N.-A. Dang, A. Sutter, R. Ross, J. Knop, S. Sudowe, and A. B. Reske-Kunz
A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid
Blood, May 1, 2007; 109(9): 3820 - 3829.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. W. Lee, L. Hertel, R. K. Louie, T. Burster, V. Lacaille, A. Pashine, D. A. Abate, E. S. Mocarski, and E. D. Mellins
Human Cytomegalovirus Alters Localization of MHC Class II and Dendrite Morphology in Mature Langerhans Cells
J. Immunol., September 15, 2006; 177(6): 3960 - 3971.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Ghadially, X.-L. Ross, C. Kerst, J. Dong, A. B. Reske-Kunz, and R. Ross
Differential Regulation of CCL22 Gene Expression in Murine Dendritic Cells and B Cells
J. Immunol., May 1, 2005; 174(9): 5620 - 5629.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Bros, X.-L. Ross, A. Pautz, A. B. Reske-Kunz, and R. Ross
The Human Fascin Gene Promoter Is Highly Active in Mature Dendritic Cells Due to a Stage-Specific Enhancer
J. Immunol., August 15, 2003; 171(4): 1825 - 1834.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
O.-M. Mykkanen, M. Gronholm, M. Ronty, M. Lalowski, P. Salmikangas, H. Suila, and O. Carpen
Characterization of Human Palladin, a Microfilament-associated Protein
Mol. Biol. Cell, October 1, 2001; 12(10): 3060 - 3073.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. Sato, H. Kawasaki, H. Nagayama, M. Enomoto, C. Morimoto, K. Tadokoro, T. Juji, and T. A. Takahashi
Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages
Int. Immunol., February 1, 2001; 13(2): 167 - 179.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Al-Alwan, G. Rowden, T. D. G. Lee, and K. A. West
Cutting Edge: The Dendritic Cell Cytoskeleton Is Critical for the Formation of the Immunological Synapse
J. Immunol., February 1, 2001; 166(3): 1452 - 1456.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Al-Alwan, G. Rowden, T. D. G. Lee, and K. A. West
Fascin Is Involved in the Antigen Presentation Activity of Mature Dendritic Cells
J. Immunol., January 1, 2001; 166(1): 338 - 345.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S.-i. Hashimoto, T. Suzuki, S. Nagai, T. Yamashita, N. Toyoda, and K. Matsushima
Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression
Blood, September 15, 2000; 96(6): 2206 - 2214.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. Brenner, C. Rossig, U. Sili, J. W. Young, and E. Goulmy
Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy
Hematology, January 1, 2000; 2000(1): 356 - 375.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. C. Adams, J. D. Clelland, G. D.M. Collett, F. Matsumura, S. Yamashiro, and L. Zhang
Cell-Matrix Adhesions Differentially Regulate Fascin Phosphorylation
Mol. Biol. Cell, December 1, 1999; 10(12): 4177 - 4190.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Ariizumi, G.-L. Shen, S. Shikano, S. Xu, R. Ritter III, T. Kumamoto, D. Edelbaum, A. Morita, P. R. Bergstresser, and A. Takashima
Identification of a Novel, Dendritic Cell-associated Molecule, Dectin-1, by Subtractive cDNA Cloning
J. Biol. Chem., June 23, 2000; 275(26): 20157 - 20167.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, R.
Right arrow Articles by Reske-Kunz, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, R.
Right arrow Articles by Reske-Kunz, A. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS